HDFC Pharma and Healthcare Fund vs NIPPON INDIA PHARMA FUND

Portfolio Overlap Analysis · Nippon vs HDFC

41.7%
High Overlap
13 common stocks · Rank #2308 of 28,282 pairs
Fund A
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma
Fund B
NIPPON INDIA PHARMA FUND
Nippon · Sectoral - Pharma

Common Holdings (10)

StockWt% in HDFC Pharma and HealthcareWt% in NIPPON INDIA PHARMAOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
9.81%13.08%9.81%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
8.38%6.56%6.56%
Lupin Limited
Pharmaceuticals & Biotechnology
6.44%7.99%6.44%
Max Healthcare Institute Limited
Healthcare Services
6.36%3.49%3.49%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
4.80%2.51%2.51%
Vijaya Diagnostic Centre Limited
Healthcare Services
2.30%3.49%2.30%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
6.21%2.20%2.20%
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
2.09%3.07%2.09%
Dr. Lal Path Labs Limited
Healthcare Services
1.63%2.05%1.63%
Thyrocare Technologies Limited
Healthcare Services
1.39%2.08%1.39%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Aster DM Healthcare Limited5.42%
  • Anthem Biosciences Limited4.46%
  • Fortis Healthcare Limited4.02%

Unique to NIPPON INDIA PHARMA

  • Dr. Reddy's Laboratories Limited5.81%
  • Cipla Limited5.67%
  • Apollo Hospitals Enterprise Limited5.17%
  • MedPlus Health Services Limited3.70%
  • Ajanta Pharma Limited3.41%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
31.6% (8)
Healthcare Services
10.1% (5)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Pharma and Healthcare

More comparisons for NIPPON INDIA PHARMA

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.